Bausch Health (BHC) r&d spend was $629M in FY2025 (+2% YoY). The tables below show the complete quarterly and annual r&d spend history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual R&D Spend
Fiscal Year
R&D Spend
YoY
2025
$629M
+2%
2024
$616M
+2%
2023
$604M
+14%
2022
$529M
+14%
2021
$465M
+3%
2020
$452M
-4%
2019
$471M
+14%
2018
$413M
+14%
2017
$361M
-14%
2016
$421M
+26%
2015
$334M
+36%
2014
$246M
+57%
2013
$157M
+98%
2012
$79M
+20%
2011
$66M
-4%
2010
$68M
+44%
2009
$48M
-32%
2008
$70M
Recent Quarterly R&D Spend
Quarter
R&D Spend
Q2 2026
$173M
Q1 2026
$163M
Q4 2025
$161M
Q3 2025
$166M
Q2 2025
$159M
Q1 2025
$143M
Q4 2024
$163M
Q3 2024
$146M
Q2 2024
$156M
Q1 2024
$151M
Q4 2023
$152M
Q3 2023
$153M
Source: BHC on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.